Hims & Hers Shares Plunge After Company Pulls $49 Compounded GLP-1 Pill Amid FDA Warning
Hims & Hers Health shares fell sharply in premarket trading after the company announced it would cease sales of a newly introduced $49 compounded GLP-1 weight-loss pill following regulatory threats from the U.S. Food and Drug Administration. The product had been launched days earlier and briefly pressured major weight-loss drugmakers' stocks before…